A preliminary economic evaluation of percutaneous neuromuscular electrical stimulation in the treatment of hemiplegic shoulder pain

Janine Astrid van Til; Gerbert J. Renzenbrink; Catharina Gerarda Maria Groothuis-Oudshoorn; Maarten Joost IJzerman

doi:10.1080/09638280500277057

A preliminary economic evaluation of percutaneous neuromuscular electrical stimulation in the treatment of hemiplegic shoulder pain

Janine Astrid van Til
, Gerbert J. Renzenbrink
, Catharina Gerarda Maria Groothuis-Oudshoorn
, Maarten Joost IJzerman

Faculty of Behavioural, Management and Social Sciences

Research output: Contribution to journal › Article › Academic › peer-review

20 Citations (Scopus)

14 Downloads (Pure)

Abstract

Objective. The objective of this study was to compare the cost-effectiveness of various treatment modalities for hemiplegic shoulder pain. Design. A stage II economic evaluation. Main outcome measures. Incremental cost effectiveness ratio of P-NMES, compared to slings and anti-inflammatory injections. Results. The incremental cost effectiveness ratio (ICER) of p-NMES, compared to anti-inflammatory injections is €6,061 (±3,285). The incremental cost of the first quality-adjusted life year after implantation of the P-NMES device compared to anti-inflammatory injections is €33,007 (±5,434). This decreases to ≈ €7,000 after 5 years, and to ≈ €5,000 after 10 survival years. Conclusion. In this early evaluation, P-NMES seems to be cost-effective according to known guidelines. Treatment with P-NMES is recommended for patients with chronic HSP.

Original language	Undefined
Pages (from-to)	645-651
Number of pages	7
Journal	Disability and rehabilitation
Volume	28
Issue number	1636734 (P/10
DOIs	https://doi.org/10.1080/09638280500277057
Publication status	Published - May 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

EWI-9173
IR-63936
METIS-237947
BSS-Biomechatronics and rehabilitation technology

Access to Document

10.1080/09638280500277057

http://eprints.eemcs.utwente.nl/secure2/9173/01/Til_DisabRehab_2006.pdf.pdf

Cite this

@article{62527440782f4d4e805eff071be0fc11,

title = "A preliminary economic evaluation of percutaneous neuromuscular electrical stimulation in the treatment of hemiplegic shoulder pain",

abstract = "Objective. The objective of this study was to compare the cost-effectiveness of various treatment modalities for hemiplegic shoulder pain. Design. A stage II economic evaluation. Main outcome measures. Incremental cost effectiveness ratio of P-NMES, compared to slings and anti-inflammatory injections. Results. The incremental cost effectiveness ratio (ICER) of p-NMES, compared to anti-inflammatory injections is €6,061 (±3,285). The incremental cost of the first quality-adjusted life year after implantation of the P-NMES device compared to anti-inflammatory injections is €33,007 (±5,434). This decreases to ≈ €7,000 after 5 years, and to ≈ €5,000 after 10 survival years. Conclusion. In this early evaluation, P-NMES seems to be cost-effective according to known guidelines. Treatment with P-NMES is recommended for patients with chronic HSP.",

keywords = "EWI-9173, IR-63936, METIS-237947, BSS-Biomechatronics and rehabilitation technology",

author = "\{van Til\}, \{Janine Astrid\} and Renzenbrink, \{Gerbert J.\} and Groothuis-Oudshoorn, \{Catharina Gerarda Maria\} and IJzerman, \{Maarten Joost\}",

note = "10.1080/09638280500277057 ",

year = "2006",

month = may,

doi = "10.1080/09638280500277057",

language = "Undefined",

volume = "28",

pages = "645--651",

journal = "Disability and rehabilitation",

issn = "0963-8288",

publisher = "Informa Healthcare",

number = "1636734 (P/10",

}

A preliminary economic evaluation of percutaneous neuromuscular electrical stimulation in the treatment of hemiplegic shoulder pain. / van Til, Janine Astrid; Renzenbrink, Gerbert J.; Groothuis-Oudshoorn, Catharina Gerarda Maria et al.
In: Disability and rehabilitation, Vol. 28, No. 1636734 (P/10, 05.2006, p. 645-651.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A preliminary economic evaluation of percutaneous neuromuscular electrical stimulation in the treatment of hemiplegic shoulder pain

AU - van Til, Janine Astrid

AU - Renzenbrink, Gerbert J.

AU - Groothuis-Oudshoorn, Catharina Gerarda Maria

AU - IJzerman, Maarten Joost

N1 - 10.1080/09638280500277057

PY - 2006/5

Y1 - 2006/5

N2 - Objective. The objective of this study was to compare the cost-effectiveness of various treatment modalities for hemiplegic shoulder pain. Design. A stage II economic evaluation. Main outcome measures. Incremental cost effectiveness ratio of P-NMES, compared to slings and anti-inflammatory injections. Results. The incremental cost effectiveness ratio (ICER) of p-NMES, compared to anti-inflammatory injections is €6,061 (±3,285). The incremental cost of the first quality-adjusted life year after implantation of the P-NMES device compared to anti-inflammatory injections is €33,007 (±5,434). This decreases to ≈ €7,000 after 5 years, and to ≈ €5,000 after 10 survival years. Conclusion. In this early evaluation, P-NMES seems to be cost-effective according to known guidelines. Treatment with P-NMES is recommended for patients with chronic HSP.

AB - Objective. The objective of this study was to compare the cost-effectiveness of various treatment modalities for hemiplegic shoulder pain. Design. A stage II economic evaluation. Main outcome measures. Incremental cost effectiveness ratio of P-NMES, compared to slings and anti-inflammatory injections. Results. The incremental cost effectiveness ratio (ICER) of p-NMES, compared to anti-inflammatory injections is €6,061 (±3,285). The incremental cost of the first quality-adjusted life year after implantation of the P-NMES device compared to anti-inflammatory injections is €33,007 (±5,434). This decreases to ≈ €7,000 after 5 years, and to ≈ €5,000 after 10 survival years. Conclusion. In this early evaluation, P-NMES seems to be cost-effective according to known guidelines. Treatment with P-NMES is recommended for patients with chronic HSP.

KW - EWI-9173

KW - IR-63936

KW - METIS-237947

KW - BSS-Biomechatronics and rehabilitation technology

U2 - 10.1080/09638280500277057

DO - 10.1080/09638280500277057

M3 - Article

SN - 0963-8288

VL - 28

SP - 645

EP - 651

JO - Disability and rehabilitation

JF - Disability and rehabilitation

IS - 1636734 (P/10

ER -